Apricyt 125 mg /80 mg Capsule | 1 Kit in 1 packet

Introduction of Apricyt 125 mg /80 mg Capsule

Apricyt 125 mg /80 mg Capsule is an neurokinin-1 antagonist class of medicine. Apricyt 125 mg /80 mg Capsule is used in adults and adolescents over 12 years of age in combination with other medicines to prevent nausea and vomiting from drugs used in chemotherapy (cancer treatment) and drugs that strongly and moderately cause nausea and vomiting (such as cisplatin, cyclophosphamide, doxorubicin or epirubicin).

Apricyt 125 mg /80 mg Capsule is not recommended for patients who are allergic to any ingredient in Apricyt Capsule. Concomitant use of Apricyt 125 mg /80 mg Capsule with pimozide, terfenadine, astemizole, or cisapride is not recommended. Apricyt Capsule can increase plasma concentrations of these drugs and cause potentially serious or life-threatening reactions. Consult your physician before using Apricyt 125 mg /80 mg Capsule.

Apricyt 125 mg /80 mg Capsule may experience some side effects including decreased appetite, indigestion, fatigue, increased ALT, anaemia, febrile neutropenia, anxiety, dizziness, drowsiness, hot flashes, nausea, gastroesophageal reflux disease, vomiting, abdominal pain, dry mouth, bloating, bloating, rashes, acne. These side effects are usually mild and go away on their own, but be sure to tell your doctor if you notice them or if they last longer than a few days.

​Apricyt 125 mg /80 mg Capsule can be taken with or without food, but it is recommended to take it at the same time each day for the best results. The dosage and frequency of administration may vary depending on the individual's condition and medical history. Your doctor will monitor the patient's response to the drug and adjust the dose as needed.

Uses of Apricyt 125 mg /80 mg Capsule

Chemotherapy Induced Nausea and Vomiting (CINV): Apricyt 125 mg /80 mg Capsule is used in the treatment of chemotherapy Induced Nausea and Vomiting (CINV), which is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.

Postoperative Nausea and Vomiting (PONV}: Apricyt Capsule is used to prevent postoperative nausea and vomiting, a common side effect of anaesthesia and surgery.

Benefits of Apricyt 125 mg /80 mg Capsule

Apricyt 125 mg /80 mg Capsule blocks the effects of chemicals in your body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused by certain medicines or cancer treatments. This Apricyt Capsule helps you recover better from cancer treatments such as radiation therapy or chemotherapy.

Side Effects of Apricyt 125 mg /80 mg Capsule

Like all medication, Apricyt 125 mg /80 mg Capsule may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects of Apricyt 125 mg /80 mg Capsule

• Dizziness
• Weakness
• Tiredness
• Diarrhoea
• Constipation
• Heartburn
• Epigastric pain
  

Common Side Effects of Apricyt 125 mg /80 mg Capsule

• Allergic skin reaction
• Severe Itching
• Difficulty in breathing
• Difficulty in swallowing
• Bloating of abdomen
• Stomach pain
• Hiccups
  

How to Use Apricyt 125 mg /80 mg Capsule?

​Apricyt 125 mg /80 mg Capsule can be taken with or without food, but it is recommended to take it at the same time each day for the best results. The dosage and frequency of administration may vary depending on the individual's condition and medical history. Your doctor will monitor the patient's response to the drug and adjust the dose as needed.

How Apricyt 125 mg /80 mg Capsule Works?

Apricyt Capsule is a combination of two different doses of aprepitant. Apricyt Capsule blocks the action of a chemical messenger in the brain that can cause nausea and vomiting during treatment with cancer drugs.

Safety Advices Apricyt 125 mg /80 mg Capsule

Kidney

Safe

Liver

Use with Caution

Driving

Unsafe

Breastfeeding

Unsafe

Pregnancy

Safe

Alcohol

Unsafe

References

1. Emend 80 Mg And 125 Mg And Capsule, Merck Sharp & Dohme (New Zealand) Limited, [date Of Revision 8 October 2021], Product Leaflet 

2. Emend (aprepitant) Capsules, F Merck & Co., Inc, Product Monograph 

3. Aprepitant 125mg/80mg Hard Capsules, Pharnathen International S.a, Product Leaflet 

4. Emend 125 Mg And 80 Mg Hard Capsules, Merck Sharp & Dohme B.v., Product Leaflet 

5. Aprepitant, A Pack Containing 1 Capsule 125 Mg And 2 Capsules 80 Mg, Emend, Australian Government Department Of Health And Aged Care, Avaliable From, Online 

6. Emend, (aprepitant) Capsules, Merck & Co., Inc, [date Of Revision May 2022], Product Leaflet